project id: TCGA-UCEC; case submitter id: TCGA-E6-A2P9; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.4; age at index: 65; days to birth: -24088; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 24088; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1386.0; figo stage: Stage IA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 230.0; sample id: 9c35e13b-87fc-4dc4-a847-dba192079ec1; sample submitter id: TCGA-E6-A2P9-01A; portion id: ac1f6b84-e195-46f2-a9ec-ab75565ce486; portion submitter id: TCGA-E6-A2P9-01A-11; slide id: 9774fa25-45d4-4d09-9c0c-69f2aee08602; slide submitter id: TCGA-E6-A2P9-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 96.0; section location: TOP;